89 related articles for article (PubMed ID: 11251886)
1. An investigation into the heparin-binding properties of a synthetic peptide deduced from the antigenic domain 2 of human cytomegalovirus glycoprotein B.
Silvestri ME; Sundqvist VA
Scand J Immunol; 2001 Mar; 53(3):282-9. PubMed ID: 11251886
[TBL] [Abstract][Full Text] [Related]
2. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1.
Kazmin DA; Hoyt TR; Taubner L; Teintze M; Starkey JR
J Mol Biol; 2000 May; 298(3):431-45. PubMed ID: 10772861
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
[TBL] [Abstract][Full Text] [Related]
5. Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain.
Trybala E; Bergström T; Spillmann D; Svennerholm B; Flynn SJ; Ryan P
J Biol Chem; 1998 Feb; 273(9):5047-52. PubMed ID: 9478954
[TBL] [Abstract][Full Text] [Related]
6. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
Lantto J; Fletcher JM; Ohlin M
Virology; 2003 Jan; 305(1):201-9. PubMed ID: 12504553
[TBL] [Abstract][Full Text] [Related]
7. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
8. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
Akula SM; Pramod NP; Wang FZ; Chandran B
Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
[TBL] [Abstract][Full Text] [Related]
10. Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties.
Barrios Y; Knör S; Lantto J; Mach M; Ohlin M
Mol Immunol; 2007 Feb; 44(5):680-90. PubMed ID: 16824601
[TBL] [Abstract][Full Text] [Related]
11. Mutations in conformation-dependent domains of herpes simplex virus 1 glycoprotein B affect the antigenic properties, dimerization, and transport of the molecule.
Qadri I; Gimeno C; Navarro D; Pereira L
Virology; 1991 Jan; 180(1):135-52. PubMed ID: 1701945
[TBL] [Abstract][Full Text] [Related]
12. A pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells.
Wu C; Wang S
J Virol; 2012 Jan; 86(1):484-91. PubMed ID: 22072779
[TBL] [Abstract][Full Text] [Related]
13. Improvement of binding of Puumala virus neutralization site resembling peptide with a second-generation phage library.
Heiskanen T; Li XD; Hepojoki J; Gustafsson E; Lundkvist A; Vaheri A; Lankinen H
Protein Eng; 2003 Jun; 16(6):443-50. PubMed ID: 12874378
[TBL] [Abstract][Full Text] [Related]
14. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
15. A peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment.
Liu S; Julian J; Carson DD
J Biol Chem; 1998 Apr; 273(16):9718-26. PubMed ID: 9545307
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.
Spaete RR; Thayer RM; Probert WS; Masiarz FR; Chamberlain SH; Rasmussen L; Merigan TC; Pachl C
Virology; 1988 Nov; 167(1):207-25. PubMed ID: 2460994
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
18. Mapping a heparin binding site on ErbB-3 epidermal growth factor receptor.
Adar R; Yayon A
Biochem Biophys Res Commun; 2001 Apr; 283(1):1-5. PubMed ID: 11322758
[TBL] [Abstract][Full Text] [Related]
19. Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide.
Drake SL; Klein DJ; Mickelson DJ; Oegema TR; Furcht LT; McCarthy JB
J Cell Biol; 1992 Jun; 117(6):1331-41. PubMed ID: 1607392
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93.
Liu YN; Curtsinger J; Donahue PR; Klaus A; Optiz G; Cooper J; Karr RW; Bach FH; Gehrz RC
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2207-14. PubMed ID: 7691989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
